| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308405 | Kidney International | 2005 | 8 Pages |
Abstract
The results indicate a strong nephroprotective effect of the vasopeptidase inhibitor in this animal model of progressive renal fibrosis. Besides the antihypertensive action of AVE7688, its antifibrotic, anti-inflammatory, and antiproteinuric effects demonstrated in the present study may serve as an important therapeutic option for chronic inflammatory and fibrotic diseases in man.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Oliver Gross, Marie-Louise Koepke, Bogdan Beirowski, Eckhard Schulze-Lohoff, Stephan Segerer, Manfred Weber,